Cellanome Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 127

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $75.9M

  • Investors
  • 11

Cellanome General Information

Description

Developer of an integrative multi-omics platform designed to link live-cell behavior with single-cell transcriptomics. The company's platform utilizes automated, light-guided hydrogel micro-enclosures to isolate, culture, and track the morphological changes of individual live cells over time before performing terminal genetic sequencing, enabling biomedical researchers to capture dynamic cellular interactions and accelerate therapeutic discovery for oncology and immunology.

Contact Information

Website
www.cellanome.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 500 Lincoln Centre Drive
  • 3rd Floor
  • Foster City, CA 94404
  • United States
+1 (650)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 500 Lincoln Centre Drive
  • 3rd Floor
  • Foster City, CA 94404
  • United States
+1 (650)

Cellanome Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellanome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 18-Jun-2026 $75.9M Completed Generating Revenue
5. Early Stage VC (Series B) 08-Jan-2024 Completed Generating Revenue
4. Early Stage VC (Series A2) 21-Mar-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 22-Nov-2021 Completed Generating Revenue
2. Seed Round 05-Oct-2021 $2.05M $4.65M Completed Generating Revenue
1. Seed Round $2.6M $2.6M Completed Startup
To view Cellanome’s complete valuation and funding history, request access »

Cellanome Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B
Series A-2
Series A
Seed 2 1,737,280 $0.000100 8% $1.18 $1.18 1x $1.18 2.02%
Seed 5,245,616 $0.000100 8% $0.5 $0.5 1x $0.5 6.08%
To view Cellanome’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cellanome Patents

  • 105

    Total Documents Applications and Grants

  • Total Patents Families

  • 30

    Granted

  • 59

    Pending

  • Expiring in next 12 mo

Cellanome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026236709-A1 Methods of analyzing cellular nucleic acids Pending 09-May-2025
US-20260297566-A1 Cellular analysis using binding agents Pending 31-Mar-2025
US-20260297669-A1 Methods for analyzing dna molecules in single cells Pending 31-Mar-2025
WO-2026148008-A1 Systems and methods for analysis of cells Pending 31-Dec-2024
WO-2026106971-A1 Flow cells and methods for analyzing a biological component Pending 12-Nov-2024 B01L3/502707
To view Cellanome’s complete patent history, request access »

Cellanome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellanome Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
DFJ Growth Venture Capital Minority
Premji Invest (US) Growth/Expansion Minority
SV Angel Venture Capital Minority
Wing Venture Capital Venture Capital Minority
8VC Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Cellanome FAQs

  • When was Cellanome founded?

    Cellanome was founded in 2020.

  • Where is Cellanome headquartered?

    Cellanome is headquartered in Foster City, CA.

  • What is the size of Cellanome?

    Cellanome has 127 total employees.

  • What industry is Cellanome in?

    Cellanome’s primary industry is Discovery Tools (Healthcare).

  • Is Cellanome a private or public company?

    Cellanome is a Private company.

  • What is the current valuation of Cellanome?

    The current valuation of Cellanome is .

  • What is Cellanome’s current revenue?

    The current revenue for Cellanome is .

  • How much funding has Cellanome raised over time?

    Cellanome has raised $292M.

  • Who are Cellanome’s investors?

    DFJ Growth, Premji Invest (US), SV Angel, Wing Venture Capital, and 8VC are 5 of 11 investors who have invested in Cellanome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process